Tenax TherapeuticsTENX
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 34 institutions reported holding Tenax Therapeutics Inc. (TENX) in their 13F filings, up 8 from Q2 2025. 11 opened new positions and 3 sold out. The largest holders were Ikarian Capital, LLC ($7.4M), Venrock Adviser, LLC ($3.3M) and RTW Investments, LP ($2.9M). 3 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Tenax Therapeutics Inc.
- CUSIP
- 88032L605
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 11 | $15.3M |
| Exits | 3 | $102K |
All 13F filers, Q2 2025 → Q3 2025: 2,609,087 shares bought and 120,321 shares sold, net +2,488,766 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 34 holders
| Ikarian Capital, LLC | 1.49% | New | 967,600 | $7.4M |
| Venrock Adviser, LLC | 0.19% | Add +344.1% | 437,708 | $3.3M |
| RTW Investments, LP | 0.04% | No change | 378,346 | $2.9M |
| Siren, L.L.C. | 0.10% | New | 352,441 | $2.7M |
| Boothbay Fund Management, LLC | 0.07% | New | 352,206 | $2.7M |
| BVF Inc. | 0.10% | No change | 339,549 | $2.6M |
| Millennium Management | 0.00% | Add +34.2% | 313,712 | $2.4M |
| Vivo Capital, LLC | 0.13% | No change | 208,333 | $1.6M |
| Morgan Stanley | 0.00% | Add +0.2% | 178,329 | $1.4M |
| Marshall Wace, LLP | 0.00% | New | 177,209 | $1.3M |
| Janus Henderson Group PLC | 0.00% | No change | 166,666 | $1.3M |
| Integral Health Asset Management, LLC | 0.09% | No change | 167,000 | $1.3M |
| Vanguard Group Inc. | 0.00% | Add +626.0% | 161,800 | $1.2M |
| Woodline Partners LP | 0.00% | New | 88,211 | $671K |
| Velan Capital Investment Management LP | 0.60% | No change | 83,333 | $634K |
| Adage Capital Partners Gp, L.L.C. | 0.00% | No change | 83,333 | $634K |
| Renaissance Technologies | 0.00% | New | 56,600 | $431K |
| Vestal Point Capital, LP | 0.02% | No change | 53,439 | $407K |
| ADAR1 Capital Management, LLC | 0.04% | Reduce -65.7% | 53,428 | $407K |
| Citadel Advisors | 0.00% | Add +318.1% | 43,253 | $329K |
| Geode Capital Management, LLC | 0.00% | Add +0.6% | 34,425 | $262K |
| Virtu Financial LLC | 0.01% | New | 12,119 | $92K |
| DRW Securities, LLC | 0.00% | New | 10,514 | $80K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -59.9% | 501 | $4K |
| BlackRock, Inc. | 0.00% | Add +0.3% | 301 | $2K |
| Bank of America Corp. | 0.00% | Add +2.0% | 254 | $2K |
| UBS Group AG | 0.00% | Add +750.0% | 119 | $906 |
| Rockefeller Capital Management L.P. | 0.00% | New | 2 | $15 |
| SBI Securities Co., Ltd. | 0.00% | New | 2 | $15 |
| Allworth Financial LP | 0.00% | No change | 1 | $8 |
| Wealthspire Advisors, LLC | 0.00% | New | 1 | $8 |
| Physician Wealth Advisors, Inc. | 0.00% | No change | 1 | $8 |
| Jones Financial Companies LLLP | 0.00% | No change | 1 | $7 |
| Union Bancaire Privee, UBP SA | 0.00% | No change | 1 | $6 |
"% of holder's portfolio" is TENX's weight in each manager's 13F, not the share of Tenax Therapeutics Inc. the manager owns.